President Massimo Scaccabarozzi tells Pimm Fox how the Italian pharmaceutical industry rose to the challenge of developing and producing the new Covid vaccine while simultaneously servicing its existing patients worldwide, and why Italian pharmaceuticals are so attractive for US investors.
